Henrietta J. Ditzen is an associate in the Düsseldorf office of Latham & Watkins and a member of the firm's Corporate Department. Henrietta focuses on transactions as well as corporate and regulatory matters in the healthcare and life sciences industries.
She has extensive experience advising financial investors in the healthcare market on:
M&A transactions
Restructurings
In the life sciences sector, Henrietta advises German and international pharmaceutical companies and medical device manufacturers with regard to:
M&A transactions
German and EU regulatory matters
Experience
Henrietta’s experience includes advising:
Acrotec on the acquisition of Friedrich Daniels GmbH
Aliaxis on the sale of a ceramics business
Antin Infrastructure Partners on the acquisition of the majority stake in amedes Holding AG, a provider of medical diagnostic services
Bregal Unternehmerkapital on the acquisition of medavis GmbH
Cheplapharm on the:
acquisition of the worldwide commercial rights (excluding South Korea) for Zyprexa® from Eli Lilly and Company
acquisition of the worldwide commercial rights (excluding South Korea) for Zyprexa® from Eli Lilly and Company
acquisition of the medicinal products Seroquel and Seroquel XR in Europe, Russia, the US, and Canada from AstraZeneca
Corpus Sireo in the sale of its real estate portfolio to Deutsche Bank subsidiary Deutsche Asset & Wealth Management, and the sale of the group of companies to Swiss Life
DPE Deutsche Private Equity and Maxburg Capital Partners on the sale of PharmaZell GmbH
EQT Partners AB on the acquisition of Siemens Audiology Solutions from Siemens
Fresenius on the sale of the majority of Vamed’s rehabilitation business to PAI Partners
Inari Medical on the acquisition of LimFlow
Juno Therapeutics on the acquisition of Stage Cell Therapeutics GmbH
Medigo GmbH on corporate and regulatory advice in connection with establishing an online platform for medical tourism
Novo Nordisk on the acquisition of Cardior Pharmaceuticals
Raptor Pharmaceuticals in connection with the product commercialization of an orphan drug in the EEA
Siemens in connection with the pending internal reorganization of its healthcare division
Stirling Square Capital Partners on the sale of Cartonplast Group to DBAG
Tecan Trading AG on the acquisition of IBL International Holding B.V., a developer and distributor of in-vitro diagnostic test systems
Thoratec Corporation on clinical trials in Germany and Austria
Trilantic on the acquisition of the Deutsche Pflege und Wohnen Group and the Argentum Group in a combined purchase procedure
TriVascular on medical device legislation and compliance
Qualifications
Bar Qualification
Rechtsanwältin (Germany)
Education
LL.M., Columbia University, 2013
Second German State Exam, Higher Regional Court, Hamburg, 2011
First German State Exam, Rheinische Friedrich-Wilhelms-Universität, Bonn, 2009
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.
